The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vagus Nerve Stimulators Market Research Report 2024
Synopsis
The global Vagus Nerve Stimulators market was valued at US$ 430 million in 2023 and is anticipated to reach US$ 617.3 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
North American market for Vagus Nerve Stimulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vagus Nerve Stimulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vagus Nerve Stimulators include BioControl Medical, Boston Scientific Corporation, CerboMed GmbH, Cerebral RX Ltd., Children's Hospital Boston, Cyberonics, DuoCure, ElectroCore, LLC and Medical University of South Carolina, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vagus Nerve Stimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagus Nerve Stimulators.
Report Scope
The Vagus Nerve Stimulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vagus Nerve Stimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagus Nerve Stimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioControl Medical
Boston Scientific Corporation
CerboMed GmbH
Cerebral RX Ltd.
Children's Hospital Boston
Cyberonics
DuoCure
ElectroCore, LLC
Medical University of South Carolina
MicroTransponder
Neurostream Technologies G.P.
Setpoint Medical Corporation
Sorin S.p.A.
Trifectas Medical
Segment by Type
Direct Vagus Nerve Stimulation
Percutaneous Vagus Nerve Stimulation
Segment by Application
Hospital
Physical Examination Center
Medical College
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagus Nerve Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagus Nerve Stimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Vagus Nerve Stimulators market was valued at US$ 430 million in 2023 and is anticipated to reach US$ 617.3 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
North American market for Vagus Nerve Stimulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vagus Nerve Stimulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vagus Nerve Stimulators include BioControl Medical, Boston Scientific Corporation, CerboMed GmbH, Cerebral RX Ltd., Children's Hospital Boston, Cyberonics, DuoCure, ElectroCore, LLC and Medical University of South Carolina, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vagus Nerve Stimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagus Nerve Stimulators.
Report Scope
The Vagus Nerve Stimulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vagus Nerve Stimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagus Nerve Stimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioControl Medical
Boston Scientific Corporation
CerboMed GmbH
Cerebral RX Ltd.
Children's Hospital Boston
Cyberonics
DuoCure
ElectroCore, LLC
Medical University of South Carolina
MicroTransponder
Neurostream Technologies G.P.
Setpoint Medical Corporation
Sorin S.p.A.
Trifectas Medical
Segment by Type
Direct Vagus Nerve Stimulation
Percutaneous Vagus Nerve Stimulation
Segment by Application
Hospital
Physical Examination Center
Medical College
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagus Nerve Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagus Nerve Stimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vagus Nerve Stimulators Market Overview
1.1 Product Overview and Scope of Vagus Nerve Stimulators
1.2 Vagus Nerve Stimulators Segment by Type
1.2.1 Global Vagus Nerve Stimulators Market Value Comparison by Type (2024-2030)
1.2.2 Direct Vagus Nerve Stimulation
1.2.3 Percutaneous Vagus Nerve Stimulation
1.3 Vagus Nerve Stimulators Segment by Application
1.3.1 Global Vagus Nerve Stimulators Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Physical Examination Center
1.3.4 Medical College
1.3.5 Other
1.4 Global Vagus Nerve Stimulators Market Size Estimates and Forecasts
1.4.1 Global Vagus Nerve Stimulators Revenue 2019-2030
1.4.2 Global Vagus Nerve Stimulators Sales 2019-2030
1.4.3 Global Vagus Nerve Stimulators Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vagus Nerve Stimulators Market Competition by Manufacturers
2.1 Global Vagus Nerve Stimulators Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vagus Nerve Stimulators Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vagus Nerve Stimulators Average Price by Manufacturers (2019-2024)
2.4 Global Vagus Nerve Stimulators Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vagus Nerve Stimulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vagus Nerve Stimulators, Product Type & Application
2.7 Vagus Nerve Stimulators Market Competitive Situation and Trends
2.7.1 Vagus Nerve Stimulators Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vagus Nerve Stimulators Players Market Share by Revenue
2.7.3 Global Vagus Nerve Stimulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vagus Nerve Stimulators Retrospective Market Scenario by Region
3.1 Global Vagus Nerve Stimulators Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vagus Nerve Stimulators Global Vagus Nerve Stimulators Sales by Region: 2019-2030
3.2.1 Global Vagus Nerve Stimulators Sales by Region: 2019-2024
3.2.2 Global Vagus Nerve Stimulators Sales by Region: 2025-2030
3.3 Global Vagus Nerve Stimulators Global Vagus Nerve Stimulators Revenue by Region: 2019-2030
3.3.1 Global Vagus Nerve Stimulators Revenue by Region: 2019-2024
3.3.2 Global Vagus Nerve Stimulators Revenue by Region: 2025-2030
3.4 North America Vagus Nerve Stimulators Market Facts & Figures by Country
3.4.1 North America Vagus Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vagus Nerve Stimulators Sales by Country (2019-2030)
3.4.3 North America Vagus Nerve Stimulators Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vagus Nerve Stimulators Market Facts & Figures by Country
3.5.1 Europe Vagus Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vagus Nerve Stimulators Sales by Country (2019-2030)
3.5.3 Europe Vagus Nerve Stimulators Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vagus Nerve Stimulators Market Facts & Figures by Country
3.6.1 Asia Pacific Vagus Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vagus Nerve Stimulators Sales by Country (2019-2030)
3.6.3 Asia Pacific Vagus Nerve Stimulators Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vagus Nerve Stimulators Market Facts & Figures by Country
3.7.1 Latin America Vagus Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vagus Nerve Stimulators Sales by Country (2019-2030)
3.7.3 Latin America Vagus Nerve Stimulators Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vagus Nerve Stimulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Vagus Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vagus Nerve Stimulators Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vagus Nerve Stimulators Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vagus Nerve Stimulators Sales by Type (2019-2030)
4.1.1 Global Vagus Nerve Stimulators Sales by Type (2019-2024)
4.1.2 Global Vagus Nerve Stimulators Sales by Type (2025-2030)
4.1.3 Global Vagus Nerve Stimulators Sales Market Share by Type (2019-2030)
4.2 Global Vagus Nerve Stimulators Revenue by Type (2019-2030)
4.2.1 Global Vagus Nerve Stimulators Revenue by Type (2019-2024)
4.2.2 Global Vagus Nerve Stimulators Revenue by Type (2025-2030)
4.2.3 Global Vagus Nerve Stimulators Revenue Market Share by Type (2019-2030)
4.3 Global Vagus Nerve Stimulators Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vagus Nerve Stimulators Sales by Application (2019-2030)
5.1.1 Global Vagus Nerve Stimulators Sales by Application (2019-2024)
5.1.2 Global Vagus Nerve Stimulators Sales by Application (2025-2030)
5.1.3 Global Vagus Nerve Stimulators Sales Market Share by Application (2019-2030)
5.2 Global Vagus Nerve Stimulators Revenue by Application (2019-2030)
5.2.1 Global Vagus Nerve Stimulators Revenue by Application (2019-2024)
5.2.2 Global Vagus Nerve Stimulators Revenue by Application (2025-2030)
5.2.3 Global Vagus Nerve Stimulators Revenue Market Share by Application (2019-2030)
5.3 Global Vagus Nerve Stimulators Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BioControl Medical
6.1.1 BioControl Medical Corporation Information
6.1.2 BioControl Medical Description and Business Overview
6.1.3 BioControl Medical Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BioControl Medical Vagus Nerve Stimulators Product Portfolio
6.1.5 BioControl Medical Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Vagus Nerve Stimulators Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 CerboMed GmbH
6.3.1 CerboMed GmbH Corporation Information
6.3.2 CerboMed GmbH Description and Business Overview
6.3.3 CerboMed GmbH Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CerboMed GmbH Vagus Nerve Stimulators Product Portfolio
6.3.5 CerboMed GmbH Recent Developments/Updates
6.4 Cerebral RX Ltd.
6.4.1 Cerebral RX Ltd. Corporation Information
6.4.2 Cerebral RX Ltd. Description and Business Overview
6.4.3 Cerebral RX Ltd. Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cerebral RX Ltd. Vagus Nerve Stimulators Product Portfolio
6.4.5 Cerebral RX Ltd. Recent Developments/Updates
6.5 Children's Hospital Boston
6.5.1 Children's Hospital Boston Corporation Information
6.5.2 Children's Hospital Boston Description and Business Overview
6.5.3 Children's Hospital Boston Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Children's Hospital Boston Vagus Nerve Stimulators Product Portfolio
6.5.5 Children's Hospital Boston Recent Developments/Updates
6.6 Cyberonics
6.6.1 Cyberonics Corporation Information
6.6.2 Cyberonics Description and Business Overview
6.6.3 Cyberonics Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cyberonics Vagus Nerve Stimulators Product Portfolio
6.6.5 Cyberonics Recent Developments/Updates
6.7 DuoCure
6.6.1 DuoCure Corporation Information
6.6.2 DuoCure Description and Business Overview
6.6.3 DuoCure Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DuoCure Vagus Nerve Stimulators Product Portfolio
6.7.5 DuoCure Recent Developments/Updates
6.8 ElectroCore, LLC
6.8.1 ElectroCore, LLC Corporation Information
6.8.2 ElectroCore, LLC Description and Business Overview
6.8.3 ElectroCore, LLC Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ElectroCore, LLC Vagus Nerve Stimulators Product Portfolio
6.8.5 ElectroCore, LLC Recent Developments/Updates
6.9 Medical University of South Carolina
6.9.1 Medical University of South Carolina Corporation Information
6.9.2 Medical University of South Carolina Description and Business Overview
6.9.3 Medical University of South Carolina Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medical University of South Carolina Vagus Nerve Stimulators Product Portfolio
6.9.5 Medical University of South Carolina Recent Developments/Updates
6.10 MicroTransponder
6.10.1 MicroTransponder Corporation Information
6.10.2 MicroTransponder Description and Business Overview
6.10.3 MicroTransponder Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MicroTransponder Vagus Nerve Stimulators Product Portfolio
6.10.5 MicroTransponder Recent Developments/Updates
6.11 Neurostream Technologies G.P.
6.11.1 Neurostream Technologies G.P. Corporation Information
6.11.2 Neurostream Technologies G.P. Vagus Nerve Stimulators Description and Business Overview
6.11.3 Neurostream Technologies G.P. Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Neurostream Technologies G.P. Vagus Nerve Stimulators Product Portfolio
6.11.5 Neurostream Technologies G.P. Recent Developments/Updates
6.12 Setpoint Medical Corporation
6.12.1 Setpoint Medical Corporation Corporation Information
6.12.2 Setpoint Medical Corporation Vagus Nerve Stimulators Description and Business Overview
6.12.3 Setpoint Medical Corporation Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Setpoint Medical Corporation Vagus Nerve Stimulators Product Portfolio
6.12.5 Setpoint Medical Corporation Recent Developments/Updates
6.13 Sorin S.p.A.
6.13.1 Sorin S.p.A. Corporation Information
6.13.2 Sorin S.p.A. Vagus Nerve Stimulators Description and Business Overview
6.13.3 Sorin S.p.A. Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sorin S.p.A. Vagus Nerve Stimulators Product Portfolio
6.13.5 Sorin S.p.A. Recent Developments/Updates
6.14 Trifectas Medical
6.14.1 Trifectas Medical Corporation Information
6.14.2 Trifectas Medical Vagus Nerve Stimulators Description and Business Overview
6.14.3 Trifectas Medical Vagus Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Trifectas Medical Vagus Nerve Stimulators Product Portfolio
6.14.5 Trifectas Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vagus Nerve Stimulators Industry Chain Analysis
7.2 Vagus Nerve Stimulators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vagus Nerve Stimulators Production Mode & Process
7.4 Vagus Nerve Stimulators Sales and Marketing
7.4.1 Vagus Nerve Stimulators Sales Channels
7.4.2 Vagus Nerve Stimulators Distributors
7.5 Vagus Nerve Stimulators Customers
8 Vagus Nerve Stimulators Market Dynamics
8.1 Vagus Nerve Stimulators Industry Trends
8.2 Vagus Nerve Stimulators Market Drivers
8.3 Vagus Nerve Stimulators Market Challenges
8.4 Vagus Nerve Stimulators Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
